Obstructive sleep apnea (OSA) consists of multiple episodes of partial or complete closure of the upper airway that occur during sleep, leading to breathing cessation lasting more than ten seconds and sometimes even several ...
Aug 23, 2023
0
2
For adults with moderate-to-severe atopic dermatitis (AD), dupilumab treatment yields significant improvement in sleep quality and other AD-related signs and symptoms, according to a study published online Aug. 10 in the ...
Aug 22, 2023
0
15
For patients with immunoglobulin A (IgA) nephropathy, nine months of treatment with targeted-release formulation of budesonide (Nefecon) yields a greater reduction in estimated glomerular filtration rate (eGFR) than placebo, ...
Aug 22, 2023
0
1
Following native tissue transvaginal prolapse repair, perioperative vaginal estrogen does not reduce prolapse recurrence, according to a study published in the Aug. 15 issue of the Journal of the American Medical Association.
Aug 21, 2023
0
3
Intravenous magnesium sulfate before preterm birth at 30 to 34 weeks of gestation does not improve child survival free of cerebral palsy, according to a study published in the Aug. 15 issue of the Journal of the American ...
Aug 17, 2023
0
1
How well can we assess the strength of our own immune system? The answer is that we are surprisingly good at this. A study by Konstanz psychologist Stephanie Dimitroff examined how freshly vaccinated people assess the strength ...
Aug 16, 2023
0
1
Treatment with modern antidepressants may help prevent patients with bipolar disorder from relapsing into a depressive episode, according to an international clinical trial led by researchers at the University of British ...
Aug 2, 2023
0
1
Road safety is a critical issue in an era of increasing cannabis legalization. Cannabis is known to impair reaction time, decision-making, coordination and perception—skills necessary for safe driving. In the last three ...
Aug 2, 2023
0
1
Maintenance therapy with selinexor provides durable survival benefits for endometrial cancer with TP53 mutations, according to a study presented during the July 2023 session of the American Society for Clinical Oncology Plenary ...
Jul 28, 2023
0
1
For patients with narcolepsy type 1, an orexin receptor 2 agonist, TAK-994, improves measures of sleepiness and cataplexy over eight weeks compared with placebo but is associated with hepatotoxic adverse events, according ...
Jul 27, 2023
0
11
